Joshua Rosen - 23 Aug 2024 Form 4 Insider Report for Vireo Growth Inc. (VREOF)

Role
CEO and Interim CFO, Director
Signature
/s/ Amber Shimpa, Attorney-in-Fact for Joshua Rosen
Issuer symbol
VREOF
Transactions as of
23 Aug 2024
Net transactions value
$0
Form type
4
Filing time
11 Oct 2024, 16:26:40 UTC
Previous filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VREOF Subordinate Voting Shares Award $0 +500,000 $0.000000 500,000 10 Oct 2024 Direct F1
holding VREOF Subordinate Voting Shares 730,014 23 Aug 2024 By Bengal Catalyst Fund LP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VREOF Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 23 Aug 2024 Subordinate Voting Shares 250,000 $0.4700 Direct F3
transaction VREOF Stock Option (right to buy) Award $0 +500,000 $0.000000 500,000 09 Oct 2024 Subordinate Voting Shares 500,000 $0.5000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Joshua Rosen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Mr. Rosen in connection with his Separation Agreement with the Company. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and vest in 12 equal installments commencing January 1, 2025 and ending on December 1, 2025.
F2 Shares owned by Bengal Catalyst Fund LP. As Managing Partner of Bengal Capital, Mr. Rosen has shared voting control over these shares.
F3 Vests in tranches of 62,500 options upon the first, second, third and fourth anniversary dates following the grant date.